ConductScience.org, home

Comparison · NCT01002482-dc7aef0f

CGAO-based Glucose Control vs Standard-Care Glucose Gontrol: Severe Hypoglycemia

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. CGAO-based Glucose Control vs Standard-Care Glucose Gontrol: Severe Hypoglycemia. Trial comparisons, record NCT01002482-dc7aef0f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01002482-dc7aef0f

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1320.1150.152wilson
Risk in group 20.06130.04950.0757wilson
Risk difference, group 1 minus group 20.07110.04860.0939newcombe hybrid score
Risk ratio, group 1 over group 22.161.682.79log
Odds ratio, group 1 over group 22.341.773.09log
Number needed to treat, for one more participant with the outcome on CGAO-based Glucose Control than on Standard-Care Glucose Gontrol14.110.720.6from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1CGAO-based Glucose ControlUse of a Computerized Protocol fot Tight Glycemic Control named CGAO software in order to maintain Blood Glucose Levels between 4.4 and 6.1 mmol/l.1741,314OG000
Group 2Standard-Care Glucose GontrolUse of Standard-Care Methods for Glucose Control targeting Blood Glucose Levels inferior to 10 mmol/l.791,289OG001

Outcome

Type
SECONDARY
Title
Severe Hypoglycemia
Description
Number of patients with severe biological hypoglycemia (defined as blood glucose of 40 mg per deciliter or less)regardless of clinical signs
Time frame
Date of discharge from the ICU
Population

Source ClinicalTrials.gov

Trial

Title
Computerized Glucose Control in Critically Ill Patients
NCT number
NCT01002482
Phases
PHASE3
Conditions
Hyperglycemia, Critical Illness
Interventions
CGAO-based Glucose Control, Standard-Care Glucose Control
Lead sponsor
Centre Hospitalier of Chartres
Results first posted
2013-12-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01002482-dc7aef0f